{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:02:56Z","timestamp":1773518576759,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35-GM127000"],"award-info":[{"award-number":["R35-GM127000"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.tox.2021.152902","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T11:37:32Z","timestamp":1629286652000},"page":"152902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in Collaborative Cross mice"],"prefix":"10.1016","volume":"461","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1968-6666","authenticated-orcid":false,"given":"Merrie","family":"Mosedale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-3794","authenticated-orcid":false,"given":"Yanwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Scott","family":"Eaddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis S.","family":"Wolenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Dragan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2419-0430","authenticated-orcid":false,"given":"William","family":"Valdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2021.152902_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22345","article-title":"Mechanistic Investigations of the Liver Toxicity of the Free Fatty Acid Receptor 1 Agonist Fasiglifam (Tak875) and Its Primary Metabolites","volume":"33","author":"Ackerson","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tox.2021.152902_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using Lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.tox.2021.152902_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc."},{"key":"10.1016\/j.tox.2021.152902_bib0020","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.redox.2014.08.006","article-title":"Examination of bioenergetic function in the inner mitochondrial membrane peptidase 2-Like (Immp2l) mutant mice","volume":"2","author":"Bharadwaj","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.tox.2021.152902_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/9780470942390.mo110217","article-title":"Health evaluation of experimental laboratory mice","volume":"2","author":"Burkholder","year":"2012","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.tox.2021.152902_bib0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00335-017-9731-6","article-title":"Advancing chemical risk assessment decision-making with population variability data: challenges and opportunities","volume":"29","author":"Chiu","year":"2018","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.tox.2021.152902_bib0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/toxsci\/kfu094","article-title":"A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis","volume":"140","author":"Church","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1534\/genetics.111.132639","article-title":"The genome architecture of the collaborative cross mouse genetic reference population","volume":"190","author":"Collaborative Cross Consortium","year":"2012","journal-title":"Genetics"},{"key":"10.1016\/j.tox.2021.152902_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.598369","article-title":"Untargeted metabolomic analysis combined with multivariate statistics reveal distinct metabolic changes in Gpr40 agonist-treated animals related to bile acid metabolism","volume":"7","author":"Doerfler","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tox.2021.152902_bib0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1086\/423738","article-title":"Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies","volume":"75","author":"Dudbridge","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tox.2021.152902_bib0055","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1541-0420.2007.00775.x","article-title":"A note on permutation tests for variance components in multilevel generalized linear mixed models","volume":"63","author":"Fitzmaurice","year":"2007","journal-title":"Biometrics"},{"key":"10.1016\/j.tox.2021.152902_bib0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1145\/2382936.2382950","article-title":"Inferring ancestry in admixed populations using microarray probe intensities","author":"Fu","year":"2012","journal-title":"Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine (Orlando, Florida: ACM)"},{"key":"10.1016\/j.tox.2021.152902_bib0065","doi-asserted-by":"crossref","DOI":"10.1289\/EHP1274","article-title":"New rodent population models may inform human health risk assessment and identification of genetic susceptibility to environmental exposures","volume":"125","author":"Harrill","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2021.152902_bib0070","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1101\/gr.090241.108","article-title":"Mouse population-guided resequencing reveals that variants in Cd44 contribute to acetaminophen-induced liver injury in humans","volume":"19","author":"Harrill","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.tox.2021.152902_bib0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/toxsci\/kfs238","article-title":"A mouse diversity panel approach reveals the potential for clinical kidney injury due to Db289 not predicted by classical rodent models","volume":"130","author":"Harrill","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0080","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"Srebps: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2021.152902_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang da","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tox.2021.152902_bib0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using David bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tox.2021.152902_bib0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.tox.2021.152902_bib0100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/dom.12693","article-title":"Long-Term Safety and Efficacy of Fasiglifam (Tak-875), a G-Protein-Coupled Receptor 40 Agonist, as Monotherapy and Combination Therapy in Japanese Patients with Type 2 Diabetes: A 52-Week Open-Label Phase Iii Study","volume":"18","author":"Kaku","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tox.2021.152902_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature10413","article-title":"Mouse genomic variation and its effect on phenotypes and gene regulation","volume":"477","author":"Keane","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tox.2021.152902_bib0110","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1534\/g3.119.400194","article-title":"Determinants of qtl mapping power in the realized collaborative cross","volume":"9","author":"Keele","year":"2019","journal-title":"G3"},{"key":"10.1016\/j.tox.2021.152902_bib0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1534\/genetics.118.300864","article-title":"Genetic drivers of pancreatic islet function","volume":"209","author":"Keller","year":"2018","journal-title":"Genetics"},{"key":"10.1016\/j.tox.2021.152902_bib0120","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41591-020-1023-0","article-title":"Polygenic architecture informs potential vulnerability to drug-induced liver injury","volume":"26","author":"Koido","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2021.152902_bib0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kft232","article-title":"Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury","volume":"137","author":"Laifenfeld","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0130","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/jat.3609","article-title":"Exogenous Recombinant Human Thioredoxin-1 Prevents Acetaminophen-Induced Liver Injury by Scavenging Oxidative Stressors, Restoring the Thioredoxin-1 System and Inhibiting Receptor Interacting Protein-3 Overexpression","volume":"38","author":"Lee","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2021.152902_bib0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.taap.2014.01.017","article-title":"Oxidative Stress\/Reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants","volume":"275","author":"Leone","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2021.152902_bib0140","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1124\/dmd.115.064121","article-title":"Fasiglifam (Tak-875) inhibits hepatobiliary transporters: a possible factor contributing to fasiglifam-induced liver injury","volume":"43","author":"Li","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2021.152902_bib0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/toxsci\/kfy253","article-title":"Quantitative systems toxicology analysis of in vitro mechanistic assays reveals importance of bile acid accumulation and mitochondrial dysfunction in Tak-875-Induced liver injury","volume":"167","author":"Longo","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0150","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s40264-018-0745-0","article-title":"Liver safety of fasiglifam (Tak-875) in patients with type 2 diabetes: review of the global clinical trial experience","volume":"41","author":"Marcinak","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.tox.2021.152902_bib0155","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ni.3119","article-title":"Guanylate-binding proteins promote activation of the Aim2 inflammasome during infection with Francisella novicida","volume":"16","author":"Meunier","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tox.2021.152902_bib0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/toxsci\/kfaa088","article-title":"Application of a rat liver drug bioactivation transcriptional response assay early in drug development that informs chemically reactive metabolite formation and potential for drug-induced liver injury","volume":"177","author":"Monroe","year":"2020","journal-title":"Toxicol. Sci.\u202f: Off. J. Soc. Toxicol."},{"key":"10.1016\/j.tox.2021.152902_bib0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00335-015-9581-z","article-title":"Informatics resources for the collaborative cross and related mouse populations","volume":"26","author":"Morgan","year":"2015","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.tox.2021.152902_bib0170","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1124\/dmd.118.082834","article-title":"Mouse population-based approaches to investigate adverse drug reactions","volume":"46","author":"Mosedale","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2021.152902_bib0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.564","article-title":"Drug-induced liver injury: advances in mechanistic understanding that will inform risk management","volume":"101","author":"Mosedale","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2021.152902_bib0180","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1021\/acs.jmedchem.9b01297","article-title":"Understanding idiosyncratic toxicity: lessons learned from drug-induced liver injury","volume":"63","author":"Mosedale","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2021.152902_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.taap.2014.06.013","article-title":"Dysregulation of protein degradation pathways may mediate the liver injury and phospholipidosis associated with a cationic amphiphilic antibiotic drug","volume":"280","author":"Mosedale","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2021.152902_bib0190","first-page":"438","article-title":"Candidate risk factors and mechanisms for tolvaptan-induced liver injury are identified using a collaborative cross approach","volume":"156","author":"Mosedale","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/toxsci\/kfz199","article-title":"Identification of candidate risk factor genes for human idelalisib toxicity using a collaborative cross approach","volume":"172","author":"Mosedale","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0200","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/0091270011409230","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the Gpr40 agonist Tak-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers","volume":"52","author":"Naik","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2021.152902_bib0205","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1534\/g3.117.041491","article-title":"Inbred strain variant database (Isvdb): a repository for probabilistically informed sequence differences among the collaborative cross strains and their founders","volume":"7","author":"Oreper","year":"2017","journal-title":"G3"},{"key":"10.1016\/j.tox.2021.152902_bib0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/toxsci\/kfx040","article-title":"Fasiglifam (Tak-875): mechanistic investigation and retrospective identification of hazards for drug induced liver injury (Dili)","volume":"163","author":"Otieno","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/gene.2013.59","article-title":"Using the emerging collaborative cross to probe the immune system","volume":"15","author":"Phillippi","year":"2014","journal-title":"Genes Immun."},{"key":"10.1016\/j.tox.2021.152902_bib0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/toxsci\/kfaa026","article-title":"Quantitative transcriptional biomarkers of xenobiotic receptor activation in rat liver for the early assessment of drug safety liabilities","volume":"175","author":"Podtelezhnikov","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125718","article-title":"Bariatric surgery induces disruption in inflammatory signaling pathways mediated by immune cells in adipose tissue: a rna-seq study","volume":"10","author":"Poitou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2021.152902_bib0230","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tig.2019.04.003","article-title":"High-diversity mouse populations for complex traits","volume":"35","author":"Saul","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.tox.2021.152902_bib0235","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clinre.2015.12.017","article-title":"Bile acids in drug induced liver injury: key players and surrogate markers","volume":"40","author":"Schadt","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.tox.2021.152902_bib0240","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12859-016-1319-8","article-title":"Sabre: a method for assessing the stability of gene modules in complex tissues and subject populations","volume":"17","author":"Shannon","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.tox.2021.152902_bib0245","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1534\/genetics.116.198838","article-title":"Genomes of the mouse collaborative cross","volume":"206","author":"Srivastava","year":"2017","journal-title":"Genetics"},{"key":"10.1016\/j.tox.2021.152902_bib0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cbi.2018.09.011","article-title":"Comparative hepatic transcriptome analyses revealed possible pathogenic mechanisms of fasiglifam (Tak-875)-Induced acute liver injury in mice","volume":"296","author":"Urano","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2021.152902_bib0255","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1534\/genetics.104.039313","article-title":"Simulating the collaborative cross: power of quantitative trait loci detection and mapping resolution in large sets of recombinant inbred strains of mice","volume":"172","author":"Valdar","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.tox.2021.152902_bib0260","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1186\/1471-2164-15-865","article-title":"Susceptibility to Klebsiella pneumonaie infection in collaborative cross mice is a complex trait controlled by at least three loci acting at different time points","volume":"15","author":"Vered","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tox.2021.152902_bib0265","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/genetics\/143.2.1013","article-title":"Confidence intervals in qtl mapping by bootstrapping","volume":"143","author":"Visscher","year":"1996","journal-title":"Genetics"},{"key":"10.1016\/j.tox.2021.152902_bib0270","first-page":"50","article-title":"Fasiglifam (Tak-875) alters bile acid homeostasis in rats and dogs: a potential cause of drug induced liver injury","volume":"157","author":"Wolenski","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.152902_bib0275","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physiolgenomics.00040.2012","article-title":"Fine-mapping diabetes-related traits, including insulin resistance, in heterogeneous stock rats","volume":"44","author":"Woods","year":"2012","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.tox.2021.152902_bib0280","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1534\/genetics.104.028902","article-title":"Using progenitor strain information to identify quantitative trait nucleotides in outbred mice","volume":"171","author":"Yalcin","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.tox.2021.152902_bib0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/clpt.2014.158","article-title":"Systems pharmacology modeling predicts delayed presentation and species differences in bile acid-mediated troglitazone hepatotoxicity","volume":"96","author":"Yang","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2021.152902_bib0290","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1128","article-title":"A general framework for weighted gene Co-expression network analysis","volume":"4","author":"Zhang","year":"2005","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.tox.2021.152902_bib0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1534\/genetics.114.166249","article-title":"Bayesian modeling of haplotype effects in multiparent populations","volume":"198","author":"Zhang","year":"2014","journal-title":"Genetics"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21002250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21002250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:47:43Z","timestamp":1759535263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X21002250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":59,"alternative-id":["S0300483X21002250"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2021.152902","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in Collaborative Cross mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2021.152902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152902"}}